FBG --- IMO the major reason that spurred our run couple years back was at that time there was a real expectation at that point that we would be generating licensing revenue with both Aranta and Biocon in the near future. Unfortunately both those avenues have so far come up bone dry and with that disappointment and failure (along with host of other factors) our PPS and market valuation just cannot get off the mat. As always ever hopeful that we (and myriad of partners) will begin executing and our market valuation will again begin to reflect the true potential here!